Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Long-term interleukin-2 assessment after conversion from a twice-daily to once-daily tacrolimus regimen in stable kidney recipients.

Umbro I, Tinti F, Mecule A, Bachetoni A, Poli L, Pignatelli A, Alessandri C, Fiacco F, D'Alessandro M, Di Natale V, Berloco PB, Valesini G, Mitterhofer AP.

Transplant Proc. 2012 Sep;44(7):1907-9. doi: 10.1016/j.transproceed.2012.06.054.

PMID:
22974867
[PubMed - indexed for MEDLINE]
2.

Interleukin-2 profiles shortly after tacrolimus conversion from a twice-daily to once-daily regimen.

Meçule A, Tinti F, Bachetoni A, Poli L, D'Alessandro M, Alessandri C, Umbro I, Nofroni I, Berloco PB, Mitterhofer AP.

Transplant Proc. 2011 May;43(4):1017-9. doi: 10.1016/j.transproceed.2011.02.047.

PMID:
21620040
[PubMed - indexed for MEDLINE]
3.

Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation.

Kolonko A, Chudek J, Wiecek A.

Transplant Proc. 2011 Oct;43(8):2950-3. doi: 10.1016/j.transproceed.2011.07.014.

PMID:
21996198
[PubMed - indexed for MEDLINE]
4.

Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.

Meçule A, Tinti F, Poli L, Bachetoni A, Umbro I, Nofroni I, Lai Q, Pretagostini R, Berloco PB, Mitterhofer AP.

Transplant Proc. 2011 May;43(4):1024-7. doi: 10.1016/j.transproceed.2011.02.049.

PMID:
21620042
[PubMed - indexed for MEDLINE]
5.

Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism.

Uchida J, Kuwabara N, Machida Y, Iwai T, Naganuma T, Kumada N, Nakatani T.

Transplant Proc. 2012 Jan;44(1):128-33. doi: 10.1016/j.transproceed.2011.11.005.

PMID:
22310596
[PubMed - indexed for MEDLINE]
6.

A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.

Hatakeyama S, Fujita T, Yoneyama T, Yoneyama T, Koie T, Hashimoto Y, Saitoh H, Funyu T, Narumi S, Ohyama C.

Transplant Proc. 2012 Jan;44(1):121-3. doi: 10.1016/j.transproceed.2011.11.022.

PMID:
22310594
[PubMed - indexed for MEDLINE]
7.

Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors.

Meçule A, Poli L, Nofroni I, Bachetoni A, Tinti F, Umbro I, Barile M, Berloco PB, Mitterhofer AP.

Transplant Proc. 2010 May;42(4):1317-9. doi: 10.1016/j.transproceed.2010.03.123.

PMID:
20534290
[PubMed - indexed for MEDLINE]
8.

Conversion from twice-daily to once-daily Tacrolimus administration in liver transplant patient: results of long term follow-up.

Giannelli V, Rossi M, Giusto M, Lucidi C, Lattanzi B, Ruffa A, Ginanni Corradini S, Mennini G, Melandro F, Lai Q, Berloco P, Merli M.

Eur Rev Med Pharmacol Sci. 2013 Oct;17(20):2718-20.

PMID:
24174352
[PubMed - indexed for MEDLINE]
Free Article
9.

Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients.

Guirado L, Cantarell C, Franco A, Huertas EG, Fructuoso AS, Fernández A, Gentil MA, Rodríguez A, Paul J, Torregrossa JV, Rodríguez A, Alonso A, Hernández D, Burgos D, Jiménez C, Jimeno L, Lauzurica R, Mazuecos A, Osuna A, Plumed JS, Ruiz JC, Zárraga S; GREAT Study Group.

Am J Transplant. 2011 Sep;11(9):1965-71. doi: 10.1111/j.1600-6143.2011.03571.x. Epub 2011 Jun 10.

PMID:
21668633
[PubMed - indexed for MEDLINE]
Free Article
10.

Reduced C0 concentrations and increased dose requirements in renal allograft recipients converted to the novel once-daily tacrolimus formulation.

de Jonge H, Kuypers DR, Verbeke K, Vanrenterghem Y.

Transplantation. 2010 Sep 15;90(5):523-9. doi: 10.1097/TP.0b013e3181e9feda.

PMID:
20592652
[PubMed - indexed for MEDLINE]
11.

Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: a single-center experience with 394 patients.

Dumortier J, Guillaud O, Boillot O.

Liver Transpl. 2013 May;19(5):529-33. doi: 10.1002/lt.23638.

PMID:
23483701
[PubMed - indexed for MEDLINE]
12.

Conversion to tacrolimus extended-release formulation: short-term clinical results.

Gallego-Valcarce E, Ortega-Cerrato A, Llamas-Fuentes F, Martinez-Fernandez G, Perez-Martinez J, Gomez-Roldan C.

Transplant Proc. 2009 Jul-Aug;41(6):2326-7. doi: 10.1016/j.transproceed.2009.06.070.

PMID:
19715909
[PubMed - indexed for MEDLINE]
13.

Long-term follow-up of stable kidney transplant recipients after conversion from tacrolimus twice daily immediate release to tacrolimus once-daily prolonged release: a large single-center experience.

Slatinska J, Rohal T, Wohlfahrtova M, Viklicky O.

Transplant Proc. 2013 May;45(4):1491-6. doi: 10.1016/j.transproceed.2012.11.017.

PMID:
23726604
[PubMed - indexed for MEDLINE]
14.

Three-month experience with tacrolimus once-daily regimen in stable renal allografts.

Diez Ojea B, Alonso Alvarez M, Aguado Fernández S, Baños Gallardo M, García Melendreras S, Gómez Huertas E.

Transplant Proc. 2009 Jul-Aug;41(6):2323-5. doi: 10.1016/j.transproceed.2009.06.048.

PMID:
19715908
[PubMed - indexed for MEDLINE]
15.

Effect of conversion from twice-daily to once-daily tacrolimus on glucose intolerance in stable kidney transplant recipients.

Tsuchiya T, Ishida K, Ito S, Deguchi T.

Transplant Proc. 2012 Jan;44(1):118-20. doi: 10.1016/j.transproceed.2011.11.027.

PMID:
22310593
[PubMed - indexed for MEDLINE]
16.

Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients.

Heffron TG, Pescovitz MD, Florman S, Kalayoglu M, Emre S, Smallwood G, Wisemandle K, Anania C, Dhadda S, Sawamoto T, Keirns J, Fitzsimmons W, First MR.

Am J Transplant. 2007 Jun;7(6):1609-15.

PMID:
17511684
[PubMed - indexed for MEDLINE]
Free Article
17.

No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus.

Midtvedt K, Jenssen T, Hartmann A, Vethe NT, Bergan S, Havnes K, Åsberg A.

Nephrol Dial Transplant. 2011 Nov;26(11):3767-72. doi: 10.1093/ndt/gfr153. Epub 2011 Apr 6.

PMID:
21471328
[PubMed - indexed for MEDLINE]
Free Article
18.

Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.

Alloway R, Steinberg S, Khalil K, Gourishankar S, Miller J, Norman D, Hariharan S, Pirsch J, Matas A, Zaltzman J, Wisemandle K, Fitzsimmons W, First MR.

Transplantation. 2007 Jun 27;83(12):1648-51.

PMID:
17589351
[PubMed - indexed for MEDLINE]
19.

A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration.

Andrés A, Budde K, Clavien PA, Becker T, Kessler M, Pisarski P, Fornara P, Burmeister D, Hené RJ, Cassuto-Viguier E; SENIOR Study Team.

Transplantation. 2009 Nov 15;88(9):1101-8. doi: 10.1097/TP.0b013e3181ba06ee.

PMID:
19898206
[PubMed - indexed for MEDLINE]
20.

Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation.

Beckebaum S, Iacob S, Sweid D, Sotiropoulos GC, Saner F, Kaiser G, Radtke A, Klein CG, Erim Y, de Geest S, Paul A, Gerken G, Cicinnati VR.

Transpl Int. 2011 Jul;24(7):666-75. doi: 10.1111/j.1432-2277.2011.01254.x. Epub 2011 Apr 5.

PMID:
21466596
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk